Thomas W Lycan

18PUBLICATIONS
54CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersRadiation therapyImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|May 28, 2025
Impact of comorbidity on immune-related adverse events and survival in older cancer patients treated with immunotherapy.

Alyssa A Guo, Mary-Peyton Knapp, Joni K Evans

|Apr 14, 2025
Mutational Profile of Blood and Tumor Tissue and Biomarkers of Response to PD-1 Inhibitors in Patients with Cutaneous Squamous Cell Carcinoma.

Mark J Chang, Daniel B Stamos, Cetin Urtis

|Mar 28, 2025
Genomic Signature for Initial Brain Metastasis Velocity (iBMV) in Non-Small-Cell Lung Cancer Patients: The Elusive Biomarker to Predict the Development of Brain Metastases?

Sarah E Glynn, Claire M Lanier, Ariel R Choi

|Dec 16, 2024
COPD and Immune Checkpoint Inhibitors for Cancer: A Literature Review.

Thomas W Lycan, Dustin L Norton, Jill A Ohar

|Oct 04, 2024
Keratin-based topical cream for radiation dermatitis during head and neck radiotherapy: a randomised, open-label pilot study.

Ryan T Hughes, Beverly J Levine, Bart A Frizzell

|Sep 14, 2024
Immune-Related Adverse Events of Genitourinary Cancer Patients, a Retrospective Cohort Study.

John C Hunting, Logan Deyo, Eric Olson

Pageof 3

Frequent Collaborators

3 joint publications

Ryan T Hughes

3 joint publications

Ralph D'Agostino

2 joint publications

Mercedes Porosnicu

2 joint publications

Sarah N Price